1. Cai, Xue-Bi, Wu, Kun-Chao, Zhang, Xiao, Qu, Jia, Jin, Zi-Bing. 2019. Whole-exome sequencing identified ARL2 as a novel candidate gene for MRCS (microcornea, rod-cone dystrophy, cataract, and posterior staphyloma) syndrome. In Clinical genetics, 96, 61-71. doi:10.1111/cge.13541. https://pubmed.ncbi.nlm.nih.gov/30945270/
2. Lee, Hani, Choi, SeokGyeong, Ha, Sojung, Yoon, Sukjoon, Kim, Woo-Young. 2022. ARL2 is required for homologous recombination repair and colon cancer stem cell survival. In FEBS open bio, 12, 1523-1533. doi:10.1002/2211-5463.13438. https://pubmed.ncbi.nlm.nih.gov/35567502/
3. Newman, Laura E, Zhou, Cheng-jing, Mudigonda, Samatha, Marobbio, Carlo Marya Thomas, Kahn, Richard A. 2014. The ARL2 GTPase is required for mitochondrial morphology, motility, and maintenance of ATP levels. In PloS one, 9, e99270. doi:10.1371/journal.pone.0099270. https://pubmed.ncbi.nlm.nih.gov/24911211/
4. Peng, Ruiqing, Men, Jianlong, Ma, Rui, Sun, Ying, Ren, Jing. 2017. miR-214 down-regulates ARL2 and suppresses growth and invasion of cervical cancer cells. In Biochemical and biophysical research communications, 484, 623-630. doi:10.1016/j.bbrc.2017.01.152. https://pubmed.ncbi.nlm.nih.gov/28137590/
5. Harrison, Benjamin R, Masson, Patrick H. 2007. ARL2, ARG1 and PIN3 define a gravity signal transduction pathway in root statocytes. In The Plant journal : for cell and molecular biology, 53, 380-92. doi:. https://pubmed.ncbi.nlm.nih.gov/18047472/